ProQR Therapeutics (PRQR) Assets Average (2022 - 2025)

ProQR Therapeutics (PRQR) has disclosed Assets Average for 4 consecutive years, with $155.4 million as the latest value for Q4 2025.

  • Quarterly Assets Average fell 5.22% to $155.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $155.4 million through Dec 2025, down 5.22% year-over-year, with the annual reading at $155.4 million for FY2025, 5.45% down from the prior year.
  • Assets Average hit $155.4 million in Q4 2025 for ProQR Therapeutics, down from $163.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $207.3 million in Q4 2022 to a low of $155.4 million in Q4 2025.
  • Historically, Assets Average has averaged $172.0 million across 4 years, with a median of $162.7 million in 2023.
  • Biggest five-year swings in Assets Average: dropped 22.05% in 2023 and later rose 1.45% in 2024.
  • Year by year, Assets Average stood at $207.3 million in 2022, then dropped by 22.05% to $161.6 million in 2023, then grew by 1.45% to $163.9 million in 2024, then fell by 5.22% to $155.4 million in 2025.
  • Business Quant data shows Assets Average for PRQR at $155.4 million in Q4 2025, $163.9 million in Q4 2024, and $161.6 million in Q4 2023.